Septest - Sepsis Diagnostic
Septest is a rapid, point-of-care test that detects critical infection markers in minutes, enabling early sepsis diagnosis and timely treatment to save lives.
Medtech, Medical Devices and Diagnostics.
Medtech Innovator & Diagnostic Specialist
I’m Alistair Wilson, a healthcare technology leader with a passion for developing diagnostic solutions that close critical gaps in patient care. As the co-founder of Septest Limited, I’m leading the creation of a groundbreaking lateral flow test to detect early signs of infection and inflammation in sepsis, providing rapid, life-saving information for clinicians across healthcare settings.
Throughout my career, I’ve focused on creating high-impact diagnostics. I developed a unique test that differentiates between neurodegenerative diseases like Alzheimer’s, Parkinson’s, and vascular dementia—bringing much-needed clarity for early diagnosis and treatment in neurology. My experience also spans diabetes diagnostics, where I’ve worked on solutions that improve disease management and accessibility for patients in both clinical and at-home environments.
My work in bioprocessing innovation has advanced patient safety by reducing infection risks in settings where sterility is essential. Previously, as Chief Strategy Officer at a leading medical laser company, I focused on identifying new market segments and crafting solutions for unmet clinical needs, which has deeply informed my approach to medtech innovation.
I’m fortunate to work alongside key partners, including the NHS and leading IP and regulatory advisors, to ensure that our diagnostics meet the highest standards of impact and accessibility. I’m driven to bring transformative diagnostic tools to the healthcare sector, where they can make a tangible difference in patient outcomes around the world.